mEGF Biotin Recombinant Protein

mEGF Biotin Recombinant Protein

Catalog Number:
P001413062ABE
Mfr. No.:
Abe32-1138
Price:
  • Size:
    10 µg
    Quantity:
    Add to Cart:
      • Overview
        • EGF Mouse Recombinant, Biotin produced in E. Coli is a non-glycosylated polypeptide chain containing 61 amino acids and having a total molecular mass of 7.0kDa. This version of EGF has a N terminal leader sequence hosting a biotin conjugation. There are 0.5 biotins for each EGF protein. Epidermal growth factor has a profound effect on the differentiation of specific cells in vivo and is a potent mitogenic factor for a variety of cultured cells of both ectodermal and mesodermal origin. The EGF precursor is believed to exist as a membrane-bound molecule which is proteolytically cleaved to generate the 53-amino acid peptide hormone that stimulates cells to divide. EGF stimulates the growth of various epidermal and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture.

          Please contact us at for specific academic pricing.

      • Properties
        • Protein Name
          Urogastrone, URG, EGF.
          Source
          E. coli
          Type
          Recombinant Proteins
          Purification
          Greater than 95.0% as determined by analysis by SDS-PAGE.
          Formulation
          The protein (0.5mg/ml) solution contains sterile PBS.
          Storage
          Should be stored at 4°C. Please do not freeze.

          * For Research Use Only. Not for use in diagnostic/therapeutics procedures.

      • Applications
        • Application Description
          The ED50 as determined by the dose-dependent proliferation of mouse BALB/c 3T3 cells is 0.14-0.2ng/ml, corresponding to a specific activity of 7.1x106units/mg.

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
    Copyright © Amerigo Scientific. All rights reserved.